Kura Oncology Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Kura Oncology, Inc. (KURA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-173.98-152.63-135.84-130.47-89.63-63.14-60.45
Depreciation & Amortization0.850.850.764.990.19-1.100.01
Stock Based Compensation33.9028.0826.3223.5812.810.000.00
Change in Working Capital286.177.82-2.98-2.906.380.074.38
Change in Accounts Payable15.2010.33-0.80-2.525.680.000.00
Change in Other Working Capital-7.21-2.510.07-0.710.710.000.00
Other Operating Activities0.520.480.0723.6512.819.410.18
Net Cash from Operating Activities134.32-124.82-110.06-104.55-69.83-54.76-48.66
Investing Activities
Capital Expenditures-0.47-0.17-0.631.15-2.170.000.00
Purchases of Investments-101.1215.73-270.66-125.69-97.770.000.00
Sales/Maturities of Investments557.93425.55303.91-125.69-97.77-46.33-79.30
Net Cash from Investing Activities-101.5915.5632.63-126.84-99.94-46.33-79.30
Financing Activities
Debt Repayment0.000.00-0.58-7.25-0.250.00-1.25
Common Stock Issued154.4294.7824.724.43469.58108.17132.17
Other Financing Activities8.600.00-0.584.4310.252.940.00
Net Cash from Financing Activities154.4294.7838.57-3.44469.33111.10132.64
Summary
Net Change in Cash187.14-14.48-38.87-234.82299.5710.024.69
Cash at Beginning of Period37.3251.8090.67325.4926.1416.1211.43
Cash at End of Period224.4637.3251.8090.88325.7026.1416.12
Free Cash Flow133.85-124.99-110.69-105.70-72.00-54.76-48.66
Supplemental Disclosures
Interest Paid1.101.060.070.780.420.430.64